Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 25 Neoplasms 12 Stomach Neoplasms 10 Endometrial Neoplasms 10 Lung Neoplasms 9 Lymphatic Metastasis 7 Melanoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Margins of Excision 2 Lymphedema 2 Hypoparathyroidism 2 Giant Cell Tumor of Bone 2

Interventions

Radiotherapy 4 Carboplatin 4 Trastuzumab 3 Fulvestrant 3 Cyclophosphamide 3 Chemotherapy, Adjuvant 3 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Docetaxel 2 repotrectinib 1 proto-oncogene protein c-fes-fps 1 palbociclib 1 neratinib 1 gallium 68 PSMA-11 1 fluciclovine F-18 1 entrectinib 1 Zolpidem 1 Vorinostat 1 Vinorelbine 1 Venlafaxine Hydrochloride 1 Thiotepa 1 Taxes 1 Tamoxifen 1 Sugars 1 Sampling Studies 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Conformal 1 Radiotherapy, Adjuvant 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Lobular × Indocyanine Green × Clear all

NCT01796041 2021-01-28

ICG

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Carcinoma, Lobular, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡